At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 25 enrolled
Drug / intervention
Hypofractionated Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot/Phase II Trial of Hypofractionated Radiotherapy to the Whole Breast Alone Before Breast Conserving Surgery
In Brief
A Phase 2 clinical trial evaluating Hypofractionated Radiation Therapy for Anatomic Stage I Breast Cancer AJCC v8 and 7 related conditions. Completed, enrolled 25 participants across 3 sites.
Detailed Summary
This phase II trial studies how well hypofractionated radiation therapy works in treating participants with breast cancer before surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartNov 2018
Primary CompletionJun 2021
Study CompletionSep 2025
TodayJul 2026
First PostedAug 10, 2018
Enrollment StartNov 20, 2018
Primary CompletionJun 30, 2021
Study CompletionSep 24, 2025
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 7.9 years ago
Interventions
Hypofractionated Radiation Therapyradiation
Undergo hypofractionated radiation therapy